NSN 6505-01-654-2233 · NIIN 016542233 · FSC 6505
NO DASHES 6505016542233
In Stock
SARGRAMOSTIM FOR INJECTION
Drugs and Biologicals
Technical characteristics
10 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CBBL | FEATURES PROVIDED | STERILE |
| AGXW | PHYSICAL FORM | FREEZE-DRIED POWDER |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MICROGRAMS 250.00 |
| CSLZ | USUAL DOSE | 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY |
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT 250.00 |
| CSGS | ADMINISTRATION | SUBCUTANEOUS AND INTRAVENOUS INFUSION |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | SARGRAMOSTIM INJECTION, 250 MCG PER VIAL, 5'S |
| FEAT | SPECIAL FEATURES | SARGRAMOSTIM 250 MCG PER VIAL; CONTAINS 250 MCG OF PRESERVATIVE-FREE LYOPHILIZED SARGRAMOSTIM; PACKAGE OF 5 VIALS; SHOULD BE REFRIGIRATED BETWEEN 2-8DEG (36-46 F); DO NOT FREEZE OR SHAKE; FOR SUBCUTANEOUS INJECTION OR IV INFUSION |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |